Avantor (AVTR) Non-Current Deferred Tax Liability (2017 - 2026)
Avantor (AVTR) recorded quarterly Non-Current Deferred Tax Liability of $550.4 million in Q1 2026, down 1.2% quarter-over-quarter from $557.1 million in Q4 2025, and little changed on a YoY basis from $550.0 million in Q1 2025.
Avantor (AVTR) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends
Avantor's Non-Current Deferred Tax Liability history runs 10 years deep, the most recent figure standing at $550.4 million for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability changed 0.07% year-over-year to $550.4 million; the TTM figure through Mar 2026 stood at $550.4 million (changed 0.07% YoY), while the FY2025 annual figure was $557.1 million, changed 0.04% from the prior year.
- Non-Current Deferred Tax Liability was $550.4 million for Q1 2026 at Avantor, down from $557.1 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $854.4 million in Q1 2022 to a low of $535.7 million in Q2 2025.
- Historically, Non-Current Deferred Tax Liability has averaged $629.6 million across 5 years, with a median of $600.6 million in 2024.
- Biggest YoY gain for Non-Current Deferred Tax Liability was 19.83% in 2022; the steepest drop was 33.07% in 2022.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $731.4 million in 2022, then declined by 16.22% to $612.8 million in 2023, then dropped by 9.06% to $557.3 million in 2024, then slipped by 0.04% to $557.1 million in 2025, then decreased by 1.2% to $550.4 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $550.4 million (Q1 2026), $557.1 million (Q4 2025), and $548.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Avantor | 6.47 Bn | 6.19 Bn | 500.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 550.40 Mn |
| Mar 31, 2026 | 550.40 Mn |
| Dec 31, 2025 | 557.10 Mn |
| Dec 31, 2025 | 557.10 Mn |
| Sep 30, 2025 | 548.50 Mn |
| Sep 30, 2025 | 548.50 Mn |
| Jun 30, 2025 | 535.70 Mn |
| Jun 30, 2025 | 535.70 Mn |
| Mar 31, 2025 | 550.00 Mn |
| Mar 31, 2025 | 550.00 Mn |
| Dec 31, 2024 | 557.30 Mn |
| Dec 31, 2024 | 557.30 Mn |
| Sep 30, 2024 | 547.30 Mn |
| Sep 30, 2024 | 547.30 Mn |
| Jun 30, 2024 | 575.40 Mn |
| Jun 30, 2024 | 575.40 Mn |
| Mar 31, 2024 | 600.60 Mn |
| Mar 31, 2024 | 600.60 Mn |
| Dec 31, 2023 | 612.80 Mn |
| Dec 31, 2023 | 612.80 Mn |